Incidence and risk of rash to mTOR inhibitors in cancer patients: A meta-analysis of randomized controlled trials.
Raji Shameem
No relevant relationships to disclose
Mario E. Lacouture
No relevant relationships to disclose
Shenhong Wu
Consultant or Advisory Role - Novartis